The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation
Open accessAbstract
Thalidomide is a potent teratogen that induces a range of birth defects, most commonly of the developing limbs. The mechanisms underpinning the teratogenic effects of thalidomide are unclear. Here we demonstrate that loss of immature blood vessels is the primary cause of thalidomide-induced teratogenesis and provide an explanation for its action at the cell biological level. Antiangiogenic but not antiinflammatory metabolites/analogues of thalidomide induce chick limb defects. Both in vitro and in vivo, outgrowth and remodeling of more mature blood vessels is blocked temporarily, whereas newly formed, rapidly developing, angiogenic vessels are lost. Such vessel loss occurs upstream of changes in limb morphogenesis and gene expression and, depending on the timing of drug application, results in either embryonic death or developmental defects. These results explain both the timing and relative tissue specificity of thalidomide embryopathy and have significant implications for its use as a therapeutic agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A series of normal stages in the development of the chick embryo
Hamburger, V., & Hamilton, H. L. (1951) · Journal of Morphology · doi:10.1002/jmor.1050880104 · Cited by 12,234
Thalidomide is an inhibitor of angiogenesis.
D'Amato, R. J., Loughnan, M. S., Flynn, E., & Folkman, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4082 · Cited by 2,454
In Vivo Imaging of Embryonic Vascular Development Using Transgenic Zebrafish
Lawson, N. D., & Weinstein, B. M. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0711 · Cited by 2,151
THALIDOMIDE AND CONGENITAL ABNORMALITIES
Mcbride, W. G. (1961) · The Lancet · doi:10.1016/s0140-6736(61)90927-8 · Cited by 1,141
A short history of thalidomide embryopathy
Lenz, W. (1988) · Teratology · doi:10.1002/tera.1420380303 · Cited by 784
Franks, M. E., Macpherson, G. R., & Figg, W. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16308-3 · Cited by 615
Self-citationGenetic evidence that FGFs have an instructive role in limb proximal–distal patterning
Mariani, F. V., Ahn, C. P., & Martin, G. R. (2008) · Nature · doi:10.1038/nature06876 · Cited by 366
Ellison, D. (1966) · The Lancet · doi:10.1016/s0140-6736(66)92099-x · Cited by 308
Inhibition of Angiogenesis by Thalidomide Requires Metabolic Activation, Which Is Species-dependent
Bauer, K. S., Dixon, S. C., & Figg, W. D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00046-x · Cited by 295
Self-citationRecognition of thalidomide defects.
Smithells, R. W., & Newman, C. G. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.10.716 · Cited by 271
Mechanism of action in thalidomide teratogenesis
Stephens, T. D., Bunde, C. J. W., & Fillmore, B. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00388-3 · Cited by 259
Thalidomide: A review of approved and investigational uses
Matthews, S. J., & McCoy, C. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80085-1 · Cited by 203
Birth and death of cells in limb development: A mapping study
Fernandez‐Teran, M., Hinchliffe, J. R., & Ros, M. A. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20916 · Cited by 146
Thalidomide induces limb deformities by perturbing the Bmp/Dkkl/Wnt signaling pathway
Knobloch, J., Shaughnessy, J. D., & Rüther, U. (2007) · The FASEB Journal · doi:10.1096/fj.06-7603com · Cited by 134
Hypothesis: Thalidomide embryopathy?proposed mechanism of action
Stephens, T. D., & Fillmore, B. J. (2000) · Teratology · doi:10.1002/(sici)1096-9926(200003)61:3<189::aid-tera6>3.0.co;2-w · Cited by 116
Defects and Disabilities of Thalidomide Children
SMITHELLS, R. W. (1973) · BMJ · doi:10.1136/bmj.1.5848.269 · Cited by 114
Hansen, J. M., & Harris, C. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978291 · Cited by 112
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells
Tamilarasan, K. P., Kolluru, G. K., Rajaram, M., Indhumathy, M., Rajendran, S., & Chatterjee, S. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-17 · Cited by 109
Thalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Lepper, E. R., Smith, N. F., Cox, M. C., Scripture, C. D., & Figg, W. D. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017777 · Cited by 95
Self-citationNew cases of thalidomide embryopathy in Brazil
Schüler‐Faccini, L., Soares, R. C., de Sousa, A. C. M., Maximino, C. M., Luna, E. J. D. A., Schwartz, I. V. D., Waldman, C., & Castilla, E. E. (2007) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20384 · Cited by 90
Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.
Ng, S. S. W., Gütschow, M., Weiß, M., Hauschildt, S., Teubert, U., Hecker, T. K., Luzzio, F. A., Kruger, E. A., Eger, K., & Figg, W. D. (2003) · PubMed · Cited by 87
Self-citationHEAD INJURY AND ADMISSION POLICY
Jennett, B., & Galbraith, S. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90970-x · Cited by 85
Zhu, W., & Nicosia, R. F. (2002) · Angiogenesis · doi:10.1023/a:1021509004829 · Cited by 71
Foetal Malformations Due to Thalidomide
Lenz, W., & Knapp, K. (1962) · Springer eBooks · doi:10.1007/978-94-011-6621-8_29 · Cited by 51
A developmental model for thalidomide defects
Tabin, C. J. (1998) · Nature · doi:10.1038/24516 · Cited by 51
Lepper, E. R., Ng, S. S. W., Gütschow, M., Weiss, M., Hauschildt, S., Hecker, T. K., Luzzio, F. A., Eger, K., & Figg, W. D. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0304820 · Cited by 51
Self-citationNg, S. S. W., Macpherson, G. R., Gütschow, M., Eger, K., & Figg, W. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0700 · Cited by 49
Self-citationTERATOGENIC EFFECTS OF THALIDOMIDE AND RELATED SUBSTANCES
Boylen, J. B., Horne, H., & Johnson, W. J. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91346-1 · Cited by 45
Why study human limb malformations?
Wilkie, A. O. M. (2003) · Journal of Anatomy · doi:10.1046/j.1469-7580.2003.00130.x · Cited by 44
Thalidomide Resistance Is Based on the Capacity of the Glutathione-Dependent Antioxidant Defense
Knobloch, J., Reimann, K., Klotz, L., & Rüther, U. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8001232 · Cited by 44
Early changes in limb buds of chick embryos after thalidomide treatment
JURAND, A. (1966) · Development · doi:10.1242/dev.16.2.289 · Cited by 43
Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs
Kumar, S. K., Raje, N. S., Hideshima, T., Ishitsuka, K., Roccaro, A. M., Shiraishi, N., Hamasaki, M., Yasui, H., Munshi, N. C., Richardson, P. G. G., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403776 · Cited by 38
Self-citationVargesson, N., & Laufer, E. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0481 · Cited by 35
Self-citation
Cited by
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Thalidomide-induced Teratogenesis: History and Mechanisms
Vargesson, N. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21096 · Cited by 912
Self-citationThalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease
Kim, J. H., & Scialli, A. R. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr088 · Cited by 659
Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment
Shovlin, C. L. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.07.001 · Cited by 502
Metadata
- Authors
- Therapontos, C., Erskine, L., Gardner, E. R., Figg, W. D., & Vargesson, N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-05-26
- Volume
- 106
- Issue
- 21
- Pages
- 8573-8578
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2077229049
- Cited by
- 254
- References
- 33
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.